Preimplantation Genetic Diagnosis Market to expand at a CAGR of 6.8% from 2015 to 2023

Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the rising prevalence of a number of genetic disorders are also encouraging the Asian population to undertake costly diagnostic procedures such as PGD.

TMR analysts project that these factors will enable the Asia preimplantation genetic diagnosis market expansion at a healthy 6.8% CAGR from 2015 to 2023. The market is expected to rise from a valuation of US$16.0 mn in 2014 to US$28.8 mn by 2023.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9989

Rising Preference for Single Gene Disorder Screening over Prenatal Diagnostic Testing to Drive Market

Preimplantation genetic diagnosis for the screening of aneuploidy held the largest share of 34.7% in the Asia PGD market in 2014. Liberal regulations pertaining to this area of diagnosis in most Asian countries is the major factor behind the high numbers of aneuploidy screening tests undertaken every year in the region. However, PGD for single gene disorder is projected to expand at the faster CAGR of 8.4% from the period between 2015 and 2023.

Increased preference of this diagnostic modality is encouraged by technological advancements and relatively high accuracy of results. Moreover, single gene disorder screening is more beneficial compared to conventional prenatal diagnostic testing in embryo, driving the market for PGD for single gene disorder.

Rising Numbers of Healthcare Facilities to Boost Asia PGD Market

Known to provide excellent medical services at highly economical rates as compared to developed regions, the healthcare industry in Asia has invited patients from world over. With continuous advancements in healthcare infrastructure, rising numbers of healthcare experts, and constantly improving diagnostic facilities, Asia is expected to be a major hub for the PGD market in the future. Many global vendors in the healthcare and diagnostics industry are extending their businesses in the region and the number of fertility clinics, hospitals, and diagnostic centers are constantly rising in the region.

Fertility clinics held a major share in the overall Asia PGD market in 2014, and are expected to exhibit a 5.9% CAGR from the period between 2015 and 2023. However, the segment of healthcare facilities is expected to expand at a much better 7.8% CAGR over the same period. The flourishing tourism industry in the region is leading to the establishment of an increasing number of IVF centers and healthcare facilities such as hospitals and diagnostic centers in the region.

Asia PGD Market to Witness Highest Traction in Southern Countries

In the next few years, the Asia PGD market is expected to witness the highest growth in Southern countries such as India and China. The high and rising rate of infertility in South Asian countries, rising disposable incomes, high percentage of women in the workforce, and availability of technologically advanced healthcare infrastructure will enable the region in presenting the most attractive growth opportunities for the Asia PGD market. Countries in Southern Asia will also benefit from the flourishing medical tourism industry during the period between 2015 and 2023.

Browse Research Report on Global Preimplantation Genetic Diagnosis Market:
http://www.transparencymarketresearch.com/asia-preimplantation-genetic-diagnosis-market.html

Vascular Access Devices Market Value Share Analysis, by Product Type in 2024

Vascular Access Devices Market: Snapshot 

The growth of the global vascular access devices market can be attributed to rising geriatric population and the increasing prevalence of cancer, diabetes, kidney failure, and various lifestyle diseases. Technological advancements in the field of vascular access have resulted in the development of new and innovative products such as anti-microbial-coated catheters and drug-coated catheters, which has reduced the incidence of catheter-related infections and complications. Innovative techniques such as ultrasound-guided catheter tip location have also increased the efficiency of catheter placement. These developments have had a significant impact on the adoption of vascular access devices across the globe. 

The vascular access devices market is projected to expand at a CAGR of 6.0% from 2016 to 2024 to reach US$8.6 bn by 2024.

Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2200

Cost Effectiveness Drives Preference for Peripheral Intravenous Catheters 

The peripheral catheters segment accounts for a large share in the global vascular access devices market. Peripheral intravenous catheters (PIVC) are the most preferred kind because of their ease of administration, lower frequency of catheter-related complications, lesser duration of usage, and cost effectiveness.

The central catheters segment is expected to witness considerable growth over the coming years due to the increasing adoption of peripherally inserted central catheters (PICC), hemodialysis catheters, and implantable ports. This can be attributed to the rising prevalence of diseases such as cancer, end-stage renal failure, and cardiovascular disease. The PICC segment is projected to expand at a faster rate due to the longer duration of use and technological advancements in catheter placement.

Rising Incidence of Cancer and Lifestyle-associated Diseases Spurs Use of Vascular Access Devices in North America

North America leads the global vascular access devices market, with a share of over 40% in 2015. The rising prevalence of cancer, cardiovascular diseases, and end-stage renal diseases supports market growth in the region. Growing geriatric population is also a key factor driving this market. Of the 2.8 million patients who underwent dialysis in 2015, around 613,000 were from North America. Moreover, an estimated 1.6 million new cancer cases were detected in the U.S. alone in 2015. These factors collectively drive the vascular access devices market in North America.

Europe also forms a key market for vascular access devices and accounted for a share of over 25% in terms of revenue in 2015. According to the WHO, Germany, Italy, and the U.K. are among nations with the highest percentage of geriatric population in the world. The prevalence of cancer, diabetes, and kidney failure is also high in these countries. The growing number of patients requiring chemotherapy, the increasing number of patients undergoing dialysis and blood transfusion, the rising geriatric population, and a higher incidence of lifestyle diseases are the key factors driving the vascular access devices market in Europe.

The market in Asia Pacific is projected to expand at a high CAGR during the forecast period. A large population base, a greater target patient pool, increasing government initiatives to provide better healthcare facilities, and rising disposable income and per capita healthcare expenditure are driving the vascular access devices market in Asia Pacific.

Major players in the global vascular access devices market include C. R. Bard, B. Braun Melsungen AG, Becton, Dickinson and Company, Fresenius Medical Care, Cook Medical, Inc., Siemens Healthineers, Baxter International, and Medtronic, Inc.

Browse Research Report on Global Vascular Access Devices Market:
http://www.transparencymarketresearch.com/vascular-access-devices-market.html